Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Chief Executive Officer
Nate is a seasoned leader and serial entrepreneur with over 30 years of experience driving success in global corporations and startups. He has led multiple ventures to successful exits, including IPOs and M&A, particularly in the MedTech and Pharma sectors. Nate has spearheaded large-scale greenfield and brownfield projects in markets like India, Mexico, and the U.S., showcasing exceptional strategic and operational leadership. He holds an MS, MBA, and JD, specializing in healthcare and IP law, which further strengthens his expertise in navigating complex business landscapes.
Chief Innovation & Medical Officer
Dr. Garg is a California board-certified physician with a strong track record in startups and business leadership. With a unique blend of clinical expertise and entrepreneurial acumen, he has been instrumental in guiding multiple ventures from concept to successful execution. His extensive experience spans across healthcare innovation, business strategy, and operational management, making him a key player in driving growth and bringing ideas to fruition.
Chief Counsel
Alex is a Corporate, Business and Real Estate Attorney, and a Member of the California State Bar. As a business solutions specialist with a strong background working with both venture capital and start-up companies, Alex has assisted in and coordinated a multitude of complex transactions, including both public and private offerings. Alex manages all legal aspects of Ayur, Inc.
Oncology - Clinical Trial
Dr. Ghassan Al-Jazayrly is a Board-Certified Oncologist and the founder California Research Institute, an independent Phase I to IV Oncology research site. Dr. Al-Jazayrly is the Principal Investigator for Oncology and General Medicine Trials. He is also a staff member of multiple hospitals, including Hollywood Presbyterian Medical Center, Glendale Memorial Hospital, and Adventist Health - Glendale. He has been practicing Oncology for more than 20 years.
Head of Biologics Development and Manufacturing
Dr. Kumar is a Biopharma industry leader with over 30 years of experience in biologics and biosimilar process development and manufacturing. He has held executive roles in CGMP-compliant facilities and successfully launched products for companies like Roche. Dr. Kumar now leads biosimilar development operations at Omexa.
SVP Corporate Strategy & Infrastructure
An Indian BioPharma industry executive with experience in various capacities for major International biopharma equipment manufacturer. Mr. Puri has over 2 decades executive experience in building biotech facilities across India. Sudhir will be leading the greenfield project for Omexa and Ayur.
Director of Regional Business Development & Market Outreach
Dr. Amit Jarewal is a senior medical professional with a distinguished career in the healthcare and aesthetics sectors. In addition to his extensive medical career, he has served as an advisor to multiple healthcare and aesthetic organizations. At Omexa, Dr. Jarewal leads the Regional Business Development and Market Outreach.
Director Of Sales and Distribution
India and International Markets
Avi Sharma is an award-winning entrepreneur recognized as Innovator of the Year 2024 by Cabinet Minister Shri S. P. Singh Baghel for his pioneering work in molecular inventions. With expertise in alternative therapies and the therapeutic potential of CBD molecules, he has built and scaled sustainable ventures. Avi has successfully partnered with leading wellness brands including Hebe, Blunt, and Cannavedic, delivering innovative, science-backed solutions to global markets. At Omexa, he leads sales and distribution strategy across India and international markets, driving growth.
Sr. General Manager -
Phoenix - 1
A Biotech industry leader with over 25 years of industry experience in various capacities in design, execution, and manufacturing of biopharmaceuticals. Mr. Viswanath is an expert in greenfield biopharma operations. He has successfully completed three greenfield biomanufacturing facility and Omexa will be his fourth greenfield project. Mr. Vishwanath will lead Omexa Biologics’ Tindivanam Complex.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.